EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitHistorischer Beitrag

Antineutrophil Cytoplasmic Antibodies: Integrating History, Pathogenesis, and Modern Diagnostics

Aravind Radhakrishnan iD, Biman Saikia iD, Aman Sharma, Seema Chhabra iD

International Journal of Rheumatic Diseases · 2026

DOI: 10.1111/1756-185x.70910 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Rheumatic Diseases, 2026. Verfasst von Aravind Radhakrishnan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Hauptthemen laut MEDLINE: Antibodies, Antineutrophil Cytoplasmic, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Die Arbeit nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antineutrophil cytoplasmic antibodies (ANCA) define a distinct group of small‐vessel vasculitides collectively termed ANCA‐associated vasculitis (AAV). Since their initial recognition as immunofluorescence patterns, ANCA have evolved into well‐characterized pathogenic autoantibodies directed primarily against proteinase 3 (PR3) and myeloperoxidase (MPO). This review integrates the historical evolution of ANCA discovery with current understanding of disease pathogenesis and contemporary diagnostic practice. We summarize key biological mechanisms underlying AAV, including genetic susceptibility, epigenetic dysregulation, neutrophil priming, complement activation via the alternative pathway, and neutrophil extracellular trap formation, which together drive endothelial injury and necrotizing vasculitis. Recognition of PR3 ANCA and MPO ANCA as pathogenic entities has reshaped disease classification and supports the concept of biologically distinct disease subsets. In parallel, laboratory diagnostics have undergone a major paradigm shift. We critically review the transition from indirect immunofluorescence‐first algorithms to immunoassay‐first strategies endorsed by the 2017 revised international consensus, highlighting the improved diagnostic performance of contemporary antigen‐specific immunoassays. The roles of automated immunofluorescence, biochip mosaic platforms, and multiparametric testing are discussed within harmonized diagnostic workflows. Emphasis is placed on strict clinical gating, quantitative antibody interpretation, and likelihood ratio‐based reporting to enhance diagnostic accuracy and reduce false‐positive results. By integrating historical, biological, and diagnostic perspectives, this review provides a practical reference framework for evidence‐based ANCA testing and interpretation in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Antineutrophil CytoplasmicAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisHumansPredictive Value of TestsBiomarkersMyeloblastinPeroxidasePrognosisHistory, 21st CenturyHistory, 20th CenturyGenetic Predisposition to DiseaseAnimals

Stichwörter der Autor:innen

ANCAANCA‐associated vasculitisautoantibody diagnosticsharmonizationimmunoassaysindirect immunofluorescencemyeloperoxidaseproteinase 3

Substanzen

Antibodies, Antineutrophil CytoplasmicBiomarkersMyeloblastinPeroxidaseMPO protein, human

Autor:innen und Institutionen

  • Department of Pathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Immunopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

ORCID-Profile: Aravind Radhakrishnan, Biman Saikia, Seema Chhabra

Zitieren

APA

Radhakrishnan, A., Saikia, B., Sharma, A., & Chhabra, S. (2026). Antineutrophil Cytoplasmic Antibodies: Integrating History, Pathogenesis, and Modern Diagnostics. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70910

Vancouver

Radhakrishnan A, Saikia B, Sharma A, Chhabra S. Antineutrophil Cytoplasmic Antibodies: Integrating History, Pathogenesis, and Modern Diagnostics. International Journal of Rheumatic Diseases. 2026. doi:10.1111/1756-185x.70910

BibTeX
@article{Radhakrishnan2026,
  author = {Radhakrishnan, Aravind and Saikia, Biman and Sharma, Aman and Chhabra, Seema},
  title = {Antineutrophil Cytoplasmic Antibodies: Integrating History, Pathogenesis, and Modern Diagnostics},
  journal = {International Journal of Rheumatic Diseases},
  year = {2026},
  doi = {10.1111/1756-185x.70910}
}
Kostenlos starten →